Bevacizumab substantially cost effective compared with aflibercept monotherapy for diabetic macular edema: JAMA Dr Ishan Kataria10 March 2023 2:30 PM GMTIntravitreous anti-vascular endothelial growth factor (VEGF) injections are the standard treatment for eyes with vision loss from diabetic macular...
Roche gets CDSCO Panel nod to import, market ophthalmic drug Faricimab solution Dr. Divya Colin6 March 2023 12:30 PM GMTNew Delhi: Granting the request for waiver of Phase III clinical trial of Faricimab 6mg/0.05mL solution for Intravitreal Injection in the country, the...
Allopurinol lowers risk of macular edema among diabetes patients Medha Baranwal16 Feb 2023 2:30 PM GMTUSA: A recent study published in Ocular Immunology and Inflammation has shown that allopurinol could reduce the risk of diabetic macular edema (DME)....
Treatment of diabetic retinopathy with Intravitreous aflibercept does not improve visual acuity: JAMA Dr. Kamal Kant Kohli10 Feb 2023 4:00 AM GMTUSA: Treatment of nonproliferative diabetic retinopathy (NPDR) with aflibercept did not improve visual acuity but resulted in significant anatomic...
Bayer submits Aflibercept 8 mg for regulatory approval in two major retinal eye diseases in EU Ruchika Sharma7 Feb 2023 8:45 AM GMTAflibercept 8 mg is being jointly developed by Bayer and Regeneron.
Double protocol therapy effectively improves visual acuity in Diabetic macular edema Dr.Niharika Harsha B18 Jan 2023 2:30 PM GMTTurkey: Recent research found that simultaneous double protocol therapy with Intravitreal Ranibizumab and Dexamethasone Implant Injections was...
Choriocapillaris flow deficit may predict risk of retinopathy and macular edema in diabetics Dr. Shravani Dali10 Jan 2023 2:30 PM GMTChoriocapillaris flow deficit may predict risk of retinopathy and macular edema in diabetics suggests a recent study published in the American Journal...
Brolucizumab shows robust visual gains and anatomical improvements in patients with DME: AJO Dr Ishan Kataria26 Dec 2022 2:30 PM GMTDiabetic macular edema (DME) is a common microvascularcomplication in patients with diabetes, and has become the leading cause ofvision loss in the...
Neutrophillia significantly associated with increased risk of macular edema in type 2 diabetes patients Medha Baranwal16 Oct 2022 4:00 PM GMTChina: Neutrophil percentage (%neutrophils) is associated with an increased diabetic macular edema (DME) risk, whereas lymphocytes percentage...
Aflibercept with higher dose given at longer interval Promising in neovascular eye disease Dr. Kamal Kant Kohli4 Oct 2022 2:30 PM GMTAflibercept 8 mg is investigational, and its safety and efficacy have not been evaluated by any regulatory authority.According to two randomized...
Roche gets European Commission approval for Vision loss drug Vabysmo Ruchika Sharma20 Sep 2022 7:15 AM GMTBasel: Roche has announced that the European Commission (EC) has approved Vabysmo (faricimab) for the treatment of neovascular or 'wet' age-related...
Does subthreshold micropulse laser provide better outcomes in diabetic macular edema treatment? Jacinthlyn Sylvia15 Sep 2022 2:00 PM GMTUK: Subthreshold micropulse laser (SML) was similar to standard laser (SL) in binocular best-corrected visual acuity (BCVA), says an article published...
